Other OTC Pharmaceuticals - Australia & Oceania

  • Australia & Oceania
  • In Australia & Oceania, the revenue generated in the market Other OTC Pharmaceuticals amounts to US$0.65bn in 2024.
  • It is expected that the market will experience yearly growth of 1.78% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, with US$7,171.00m in 2024.
  • Taking into account the total population, per person revenues of US$15.05 are generated in 2024.
  • Australia & Oceania has seen a rise in demand for natural and alternative remedies in the Other OTC Pharmaceuticals market.

Key regions: Europe, Germany, United States, Brazil, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Australia & Oceania is experiencing steady growth due to various factors such as customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Other OTC Pharmaceuticals market in Australia & Oceania are driven by the increasing demand for self-medication and the convenience of purchasing over-the-counter drugs without a prescription. Consumers are becoming more proactive in managing their health and are seeking accessible and affordable healthcare solutions. This has led to a rise in the consumption of over-the-counter pharmaceuticals, which are readily available in pharmacies and retail stores across the region.Trends in the market show a growing focus on natural and herbal remedies, as consumers are becoming more health-conscious and are seeking alternative treatments with fewer side effects. There is a rising demand for products that are perceived as more natural and sustainable, which has led to the development of a wide range of herbal and homeopathic remedies in the market. Additionally, there is an increasing trend towards online purchasing of over-the-counter pharmaceuticals, as consumers seek the convenience of shopping from home and the ability to compare prices and read reviews before making a purchase.Local special circumstances in Australia & Oceania also contribute to the development of the Other OTC Pharmaceuticals market. The region has a high prevalence of chronic diseases such as cardiovascular diseases, diabetes, and respiratory conditions, which require long-term management. This has created a demand for over-the-counter pharmaceuticals that can help individuals manage their conditions and improve their quality of life. Additionally, the aging population in the region is driving the demand for products that address age-related health issues such as joint pain, cognitive decline, and vision problems.Underlying macroeconomic factors also play a role in the growth of the Other OTC Pharmaceuticals market in Australia & Oceania. The region has a stable economy with increasing disposable incomes, which allows consumers to spend more on healthcare products. Furthermore, the growing middle class in emerging economies within the region is driving the demand for over-the-counter pharmaceuticals, as these consumers have more purchasing power and are willing to spend on healthcare products to improve their well-being.In conclusion, the Other OTC Pharmaceuticals market in Australia & Oceania is developing due to customer preferences for self-medication and convenience, market trends towards natural and herbal remedies, local special circumstances such as the prevalence of chronic diseases and an aging population, and underlying macroeconomic factors such as increasing disposable incomes and a growing middle class. This market is expected to continue growing as consumers prioritize their health and seek accessible and affordable healthcare solutions.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)